Together, our integrated multi‐omics analysis establishes ZFPL1 as a tumor cell‐enriched gene in CRC, validated across scRNA‐seq datasets and protein‐level assays, whose high expression correlates with aggressive clinicopathological features and poor patient survival outcomes. Here, ZFPL1 is linked to neoplasm.